Edison Investment Research is terminating coverage on Intec Pharma (NTEC). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.
10 Jan 2019
Intec Pharma - Termination of coverage
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Intec Pharma - Termination of coverage
Edison Investment Research is terminating coverage on Intec Pharma (NTEC). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.